• 검색 결과가 없습니다.

경희대학교 의과대학·의학전문대학원

N/A
N/A
Protected

Academic year: 2021

Share "경희대학교 의과대학·의학전문대학원"

Copied!
77
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

Operation of Acyanotic Cong

enital Heart Disease

Department of Thoracic & Cardiovascular Surge ry, Kyung Hee University Hospital

(2)
(3)

Acyanotic CHD according to the Main P

hysiologic Load

• Lesions with Volume Load

1. L-R shunt : ASD, VSD, AVSD, PDA

2. Valve regurgitation : AVSD, MR, TR, AR 3. Cardiomyopathy

• Lesions with Pressure Load

1. Obstruction of Ventricular Outlet : PS, AS, CoA 2. Obstruction of Atrioventricular valve : MS, TS

(4)

Common Lt-to-Rt Shunt Lesions

• Atrial septal defect

• Ventricular septal defect

• Patent ductus arteriosus

• Atrio-ventricular septal defect (Endoca

rdial cushion defect)

(5)

Congenital Heart Diseases Congenital Heart Diseases VSD (30  60%) VSD (30  60%) PDA(10%) PDA(10%) ASD(7%) ASD(7%) PS(7%) PS(7%) TOF(5%) TOF(5%) AS(5%) AS(5%) TGA(5%) TGA(5%) CoA(5%) CoA(5%)

(6)

Atrial Septal Defect

(ASD)

(7)

Atrial Septal Defect

• Magnitude of the left-to-rig ht shunt

: relative compliance of the RV and LV • Enlargement of RA,RV,MP A, PVM  on chest PA • RBBB pattern (rsR’ in V1) in the ECG • Heart m. : through PV, TV, widely split and fixed S2

Sinus venosus; 1,3 Secundum; 2, 5 Primum; 4

(8)

ASD

• Rarely symptomatic in infancy & childhood • In some infant ; CHF & growth failure

• CHF : rare < 10 yr, common > 40 yr

• Atrial arrhythmia increasing with age; > 40yr • Pulmonary vascular obstructive disease

; 5 ~ 10% of all ASD

(9)

Treatment

• Qp/Qs >1.5

• 3 ~ 4 yrs.

(10)
(11)

ASD Operation

우심 방

(12)
(13)
(14)

Ventricular Septal Defect (VS

D)

(15)
(16)

VSD

(17)

VSD Types

Soto Classification (popular):

1. Perimembranous type (m/c)

i) inlet extension

ii) trabecular extension

iii) outlet extension

2. Muscular type 3. Subarterial type

Kirklin Classification (classic):

1. Type I ; SA + Infundibular

2. Type II ; PM

3. Type III ; AV canal (PMIE)

4. Type IV ; Muscular (except infundibular)

(18)

Natural Courses of VSD

• Spontaneous closure

• Pulmonary hypertension

• RVOTO

• Aortic regurgitation

• Infective endocarditis

(19)

Op. Indication & Timing of

VSD

• Indication:

1. Large VSD w/ CHF, failure of thrive, PHT 2. Subarterial type

3. Aortic valve prolapse or AR 4. Secondary RVOTO or DCRV 5. LV to RA shunt

6. s/p Infective endocarditis

• Timing:

1. Large VSD w/ CHF, severe PHT ; soon after diag nosis is made (regardless of age & BWt.)

(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)

Patent Ductus Arteriosus (PD

A)

(30)

PDA : Treatment

• In preterm ; indomethacin (Pontal) ; surgical ligation

• Older infants and children

; soon after diagnosis is made

1. Catheter closure ; coil or device 2. Surgery

(31)
(32)
(33)

Caution !!!

Recurrent laryngeal nerve injury

(34)
(35)

Atrioventricular Septal Defect

(AVSD)

(36)

Atrioventricular Septal Defect

Endocardial cushion defect (ECD)

• Anomalies at the site of atri oventricular septum and atri oventricular valves

• Down syndrome

(37)

Complete AVSD

• Symptom; early in infancy

1. Large PBF

2. Increased PAP

3. AV valve insufficiency

• Severe PVOD can occur even in infants

• Surgery; before 1 yr. (3-8 mo.)

• Special problems

- parachute MV, double orifice MV - subaortic stenosis

(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)

Partial Anomalous Pulmonary

Venous Return (PAPVR)

- Pulmonary vein 의 일부가 우심방이나 체

정맥으로 이상 연결되는 상태

- 단독으로 나타날 수도 있으나 Sinus veno

sus type 의 ASD 와 합병되어 나타날 수도

있다 .

(46)
(47)
(48)
(49)

Obstructive Lesions

• AS (LVOTO) 1. Valvular 2. Subaortic 3. Supravalvar • PS (RVOTO) 1. Valvular 2. Subvalvar(infundubular), DCRV 3. Supravalvar • CoA

(50)

Aortic Stenosis

(AS)

(51)
(52)
(53)
(54)

• Severity of AS

1. PG; in compensated asymptomatic patient < 25 mmHg 25-50 ; 50-75 ; op or intervention > 75 ; op or intervention

2. LV function ; especially in infancy 3. Hypertrophy, ischemic change, MR

4. Strain pattern on ECG, abnormal TMT 5. Symptoms ; angina, syncope, DOE

(55)

• Treatment

1. Surgical valvotomy 2. Balloon valvuloplasty 3. Valve replacement Mechanical Homograft A

utograft ; Ross operation

• Hypoplastic left heart ; Norwood op

(56)

LVOTO - Valvular AS

1 m/M

(57)
(58)
(59)
(60)
(61)
(62)

LVOTO

• Subaortic stenosis

1. A progressive lesion

2. Operation; PG > 35-40 mmHg or AR

3. Recurrent; complete resection, Konno op.

• Supravalvar AS

1. Coronary arteries, arch vessels, renal artery 2. Operation; PG > 40 mmHg

(63)
(64)
(65)
(66)

Pulmonary Stenosis

(PS)

(67)

PS - RVOTO

1. Isolated valvular PS ; 80-90% of RVOTO 2. DCRV ; anomalous muscle bundle

3. Primary infundibular PS 4. Peripheral PS

5. PS associated with systemic disease ; Noonan syndrome, tumor,

(68)
(69)

PS - Valvular

• Treatment : more than moderate PS

1. Balloon valvuloplasty : choice 2. Surgery

PG(mmHg) p(RV/LV) %

Mild < 40 < 50

Moderate 40-60 50-75

(70)
(71)
(72)

Coarctation of The Aorta

(COA)

(73)
(74)
(75)
(76)
(77)

Thank

Thank

You

참조

관련 문서

The cucumber sprouts pre-treated with all seven rhizobacterial strains at concentration of 5.0×10 6 cfu/ml were significantly increased plant height and

ITEM 7 : Declare destructors virtual in polymorphic base classes ITEM 7 : Declare destructors virtual in polymorphic base classes. „ Non-virtual vs

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

사망원인통계DB

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the

1) Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Yates, B.S., Jørgen Vestbo, M.D.,

The foreign policy triumphs with China and the Soviet Union and the administration’s announcement that peace “is at hand” in Vietnam helped reelect Nixon as

GRIPHON Prostacyclin (PGI2) Receptor Agonist In Pulmonary Arterial Hypertension IPAH idiopathic pulmonary arterial hypertension MCTD mixed connective tissue